Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.090
Filtrar
2.
Int J Mol Sci ; 25(18)2024 Sep 19.
Artigo em Inglês | MEDLINE | ID: mdl-39337558

RESUMO

Meningiomas are predominantly benign tumors, but there are also malignant forms that are associated with a poor prognosis. Like almost all tumors, meningiomas metabolize glucose as part of aerobic glycolysis (Warburg effect) for energy supply, so there are attempts to influence the prognosis of tumor diseases using a glucose-reduced diet. This altered metabolism leads to so called hallmarks of cancer, such as glycation and glycosylation. In this study, we investigated the influence of low (3 mM), normal (5.5 mM) and high glucose (15 mM) on a malignant meningioma cell line (IOMM-Lee, WHO grade 3). In addition, the influence of methylglyoxal, a by-product of glycolysis and a precursor for glycation, was investigated. Impedance-based methods (ECIS and RTCA) were used to study migration and invasion, and immunoblotting was used to analyze the expression of proteins relevant to these processes, such as focal adhesion kinase (FAK), merlin or integrin ß1. We were able to show that low glucose reduced the invasive potential of the cells, which was associated with a reduced amount of sialic acid. Under high glucose, barrier function was impaired and adhesion decreased, which correlated with a decreased expression of FAK.


Assuntos
Movimento Celular , Glucose , Neoplasias Meníngeas , Meningioma , Humanos , Meningioma/metabolismo , Meningioma/patologia , Movimento Celular/efeitos dos fármacos , Glucose/metabolismo , Glucose/farmacologia , Linhagem Celular Tumoral , Glicosilação , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Invasividade Neoplásica , Aldeído Pirúvico/metabolismo , Aldeído Pirúvico/farmacologia , Adesão Celular/efeitos dos fármacos
3.
Turk J Med Sci ; 54(4): 735-743, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39295608

RESUMO

Background/aim: Meningiomas are the most common primary brain tumors of the central nervous system. Immunotherapy is a promising treatment method applied in many types of cancer. There is no standard and effective medical treatment to reduce recurrence and mortality in cases of incomplete resection of meningiomas and in high-grade cases. In order to investigate medical treatments in addition to surgery and radiotherapy, in this study, the status of immune checkpoint molecules (PD-L1/PD-1), which are the target of immunotherapy, in meningiomas was investigated. Materials and methods: Four hundred two cases of meningioma diagnosed between 2007 and 2020 at our institution were used. New blocks were prepared from the appropriate blocks of the cases using the tissue microarray method. Sections obtained from these blocks were immunohistochemically stained with PD-1 and PD-L1 antibodies. Obtained data were interpreted with statistical analysis. Results: Expression of PD-L1 was observed in 28.4% of meningiomas. Staining rates are higher in high-grade tumors. The staining rate of PD-L1 in the tumor increased significantly with pattern loss. PD-L1 expression in immune cells is 19.9%. Immune cell expression and the number of expressing immune cells correlate with spontaneous necrosis. Immune cell expression and the number of expressing immune cells are increased in high-grade meningiomas. PD-1 expression in immune cells is 9.0%, and this correlates with brain invasion. Conclusions: With these data, it was observed that the expression of immune checkpoint molecules PD-L1 and PD-1 increased especially in high-grade meningiomas. It may be the subject of research that these molecules may be targets of immunotherapy in the treatment of meningiomas.


Assuntos
Antígeno B7-H1 , Imuno-Histoquímica , Neoplasias Meníngeas , Meningioma , Receptor de Morte Celular Programada 1 , Humanos , Meningioma/patologia , Meningioma/imunologia , Meningioma/metabolismo , Antígeno B7-H1/análise , Antígeno B7-H1/metabolismo , Masculino , Feminino , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/imunologia , Pessoa de Meia-Idade , Receptor de Morte Celular Programada 1/metabolismo , Receptor de Morte Celular Programada 1/análise , Idoso , Adulto , Biomarcadores Tumorais/metabolismo , Biomarcadores Tumorais/análise , Idoso de 80 Anos ou mais , Imunoterapia , Adulto Jovem
4.
Nat Commun ; 15(1): 7873, 2024 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-39251601

RESUMO

Meningiomas are associated with inactivation of NF2/Merlin, but approximately one-third of meningiomas with favorable clinical outcomes retain Merlin expression. Biochemical mechanisms underlying Merlin-intact meningioma growth are incompletely understood, and non-invasive biomarkers that may be used to guide treatment de-escalation or imaging surveillance are lacking. Here, we use single-cell RNA sequencing, proximity-labeling proteomic mass spectrometry, mechanistic and functional approaches, and magnetic resonance imaging (MRI) across meningioma xenografts and patients to define biochemical mechanisms and an imaging biomarker that underlie Merlin-intact meningiomas. We find Merlin serine 13 (S13) dephosphorylation drives meningioma Wnt signaling and tumor growth by attenuating inhibitory interactions with ß-catenin and activating the Wnt pathway. MRI analyses show Merlin-intact meningiomas with S13 phosphorylation and favorable clinical outcomes are associated with high apparent diffusion coefficient (ADC). These results define mechanisms underlying a potential imaging biomarker that could be used to guide treatment de-escalation or imaging surveillance for patients with Merlin-intact meningiomas.


Assuntos
Imageamento por Ressonância Magnética , Neoplasias Meníngeas , Meningioma , Neurofibromina 2 , Via de Sinalização Wnt , Meningioma/diagnóstico por imagem , Meningioma/metabolismo , Meningioma/patologia , Meningioma/genética , Humanos , Fosforilação , Neurofibromina 2/metabolismo , Neurofibromina 2/genética , Animais , Imageamento por Ressonância Magnética/métodos , Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/genética , Camundongos , Linhagem Celular Tumoral , beta Catenina/metabolismo , beta Catenina/genética , Feminino , Serina/metabolismo , Masculino , Proteômica/métodos , Biomarcadores Tumorais/metabolismo , Biomarcadores Tumorais/genética
5.
J Histochem Cytochem ; 72(8-9): 585-599, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39180315

RESUMO

Primary malignancies of the central nervous system account for 2% of all cancers in adults and almost 15% in children under 15 years of age. The prognosis of brain anaplastic cancers and glioblastomas remains extremely poor, with devastating survival expectative, and new molecular markers and therapeutic targets are essential. Epigenetic changes constitute an extensive field for the development of new diagnostic and therapeutic strategies. Histone acetyl transferase-1 (HAT1) has merged as a potential prognostic marker and therapy target for different malignancies. Data repository analysis showed HAT1 mRNA overexpression in gliomas and has been described its alternative splicing in glioblastomas. Using immunohistochemical and aptahistochemical methods, we analyzed the expression of HAT1 in meningiomas, oligodendrogliomas, and astroglial cancers. We observed that HAT1 overexpression is associated with the most aggressive tumor types and the worse prognosis, as well as with a higher probability of early relapse in meningiomas. Its cytosolic localization correlates with tumor progression and prognosis. Aptamers, synthetic oligonucleotides capable to bind and inhibit a wide variety of targets, are considered as promising diagnostic and therapeutic tools. Aptahistochemistry using the aptamer apHAT610 offered superior results in comparison with the antibody used, as a good example of the potential of aptamers as diagnostic tools for histopathology.


Assuntos
Neoplasias Encefálicas , Histona Acetiltransferases , Imuno-Histoquímica , Neoplasias Meníngeas , Humanos , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/genética , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/genética , Neoplasias Meníngeas/metabolismo , Prognóstico , Feminino , Masculino , Pessoa de Meia-Idade , Histona Acetiltransferases/genética , Histona Acetiltransferases/metabolismo , Histona Acetiltransferases/análise , Adulto , Idoso , Glioma/patologia , Glioma/diagnóstico , Glioma/metabolismo , Glioma/genética , Meningioma/patologia , Meningioma/diagnóstico , Meningioma/genética , Meningioma/metabolismo , Meningioma/enzimologia , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Biomarcadores Tumorais/análise , Gradação de Tumores
6.
Oncogene ; 43(41): 3049-3061, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39179860

RESUMO

Meningioma and schwannoma are common tumours of the nervous system. They occur sporadically or as part of the hereditary NF2-related schwannomatosis syndrome. There is an unmet need for new effective drug treatments for both tumour types. In this paper, we demonstrate overexpression/activation of TAM (TYRO3/AXL/MERTK) receptors (TAMs) and overexpression/release of ligand GAS6 in patient-derived meningioma tumour cells and tissue. For the first time, we reveal the formation of MERTK/TYRO3 heterocomplexes in meningioma and schwannoma tissue. We demonstrate the dependence of AXL and TYRO3 expression on MERTK in both tumour types, as well as interdependency of MERTK and AXL expression in meningioma. We show that MERTK and AXL contribute to increased proliferation and survival of meningioma and schwannoma cells, which we inhibited in vitro using the MERTK/FLT3 inhibitor UNC2025 and the AXL inhibitor BGB324. UNC2025 was effective in both tumour types with superior efficacy over BGB324. Finally, we found that TAMs are expressed by tumour-associated macrophages in meningioma and schwannoma tumours and that UNC2025 strongly depleted macrophages in both tumour types.


Assuntos
Receptor Tirosina Quinase Axl , Macrófagos , Neoplasias Meníngeas , Meningioma , Neurilemoma , Proteínas Proto-Oncogênicas , Receptores Proteína Tirosina Quinases , c-Mer Tirosina Quinase , c-Mer Tirosina Quinase/genética , c-Mer Tirosina Quinase/metabolismo , Humanos , Meningioma/patologia , Meningioma/genética , Meningioma/metabolismo , Neurilemoma/patologia , Neurilemoma/genética , Neurilemoma/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Receptores Proteína Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/genética , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/tratamento farmacológico , Macrófagos/metabolismo , Macrófagos/patologia , Linhagem Celular Tumoral , Neurofibromina 2/genética , Neurofibromina 2/metabolismo , Proliferação de Células , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular/genética , Neurofibromatose 2/genética , Neurofibromatose 2/patologia , Neurofibromatose 2/metabolismo , Benzocicloeptenos/farmacologia , Adenina/análogos & derivados , Piperazinas , Triazóis
7.
Anal Cell Pathol (Amst) ; 2024: 5573892, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39131899

RESUMO

Among autophagic-related proteins, p62/SQSTM1/Sequestosome-1 represents a relevant actor in cellular proliferation and neoplastic growth. Although, recently, p62 expression has been analyzed in different neurodegenerative and glial neoplastic diseases, no available information have been reported in meningiomas, which have an high epidemiological relevance being the second most common category of intracranial tumors after gliomas. Generally meningiomas have a benign behavior, but their recurrence is not uncommon mainly when atypical or anaplastic varieties occur. However, intranuclear vacuoles have been ultrastructurally observed in meningiomas, and they were labelled by p62 antibodies. Therefore, in the present study, we have investigated p62 immunohistochemical pattern in a cohort of 133 cases representative of low- and high-grade meningiomas, to verify if p62 expression may be related to clinicopathological data, thus achieving a potential prognostic role. The p62 immunoexpression was frequently found in the nucleus and cytoplasm of neoplastic elements, and utilizing an intensity-distribution score, 55 (41.3%) cases were considered as high expressors while 78 (58.7%) cases were instead recorded as low expressors. Fifteen cases exhibited recurrences of the disease, 14 of which were codified as high expressors. Moreover, a direct relationship between p62 and Mib-1 immunoexpression as well as between p62 and neoplastic grade have been documented. Finally, we suggest that impaired autophagic flux with an increase in p62 expression may be involved in the activation of NRF2 also contributing in the development of recurrence in meningioma patients.


Assuntos
Imuno-Histoquímica , Neoplasias Meníngeas , Meningioma , Gradação de Tumores , Proteína Sequestossoma-1 , Humanos , Meningioma/metabolismo , Meningioma/patologia , Proteína Sequestossoma-1/metabolismo , Feminino , Masculino , Pessoa de Meia-Idade , Idoso , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Adulto , Idoso de 80 Anos ou mais , Recidiva Local de Neoplasia/metabolismo , Recidiva Local de Neoplasia/patologia
9.
Asian Pac J Cancer Prev ; 25(8): 2735-2742, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-39205571

RESUMO

OBJECTIVE: To analyze the association between fibulin-2 and Ki-67 index with histopathological grade and other clinicopathological factors in patients with meningioma among the Minangkabau ethnic group. METHODS: This cross-sectional observational study uses 50 specimens comprising 25 low-risk meningioma cases and 25 high-risk meningioma cases obtained at three anatomical pathology laboratories in Padang, West Sumatra, Indonesia, between 2019 and 2022. All samples were stained using an immunohistochemistry procedure with Ki-67 and fibulin-2. The chi-square test was used to assess IBM SPSS statistics version 26 for Windows was used to assess the association of Ki-67 and fibulin-2 with the histopathological grade. The p-value of <0.05 was considered significant. RESULT: We found a significant association between Ki-67 (p = 0.013) or fibulin-2 (p = 0.001) expression with histopathological grade of meningioma. High histopathological grade has high expression of Ki-67 and fibulin-2, with Odds ratio (OR) of 13.500 (1.556-117.137) and 10.028 (2,738-36,722), respectively. Fibulin-2 expression was also associated with the age of patients (p = 0.020). The low age group (<50) has high expression of fibulin-2 (OR 0.196 (0.056-0.691).  Conclusion: Ki-67 and fibulin-2 were associated with the histopathological grade of meningioma, while fibulin-2 is also associated with age in the Minangkabau ethnic group.


Assuntos
Biomarcadores Tumorais , Antígeno Ki-67 , Neoplasias Meníngeas , Meningioma , Humanos , Meningioma/patologia , Meningioma/metabolismo , Feminino , Masculino , Prognóstico , Estudos Transversais , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Pessoa de Meia-Idade , Antígeno Ki-67/metabolismo , Biomarcadores Tumorais/metabolismo , Adulto , Indonésia/epidemiologia , Proteínas de Ligação ao Cálcio/metabolismo , Idoso , Seguimentos , Etnicidade , Gradação de Tumores , Proteínas da Matriz Extracelular
10.
FASEB J ; 38(13): e23737, 2024 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-38953724

RESUMO

Meningiomas are the most common primary intracranial tumors and account for nearly 30% of all nervous system tumors. Approximately half of meningioma patients exhibit neurofibromin 2 (NF2) gene inactivation. Here, NF2 was shown to interact with the endoplasmic reticulum (ER) calcium (Ca2+) channel inositol 1,4,5-trisphosphate receptor 1 (IP3R1) in IOMM-Lee, a high-grade malignant meningioma cell line, and the F1 subdomain of NF2 plays a critical role in this interaction. Functional assays indicated that NF2 promotes the phosphorylation of IP3R (Ser 1756) and IP3R-mediated endoplasmic reticulum (ER) Ca2+ release by binding to IP3R1, which results in Ca2+-dependent apoptosis. Knockout of NF2 decreased Ca2+ release and promoted resistance to apoptosis, which was rescued by wild-type NF2 overexpression but not by F1 subdomain deletion truncation overexpression. The effects of NF2 defects on the development of tumors were further studied in mouse models. The decreased expression level of NF2 caused by NF2 gene knockout or mutation affects the activity of the IP3R channel, which reduces Ca2+-dependent apoptosis, thereby promoting the development of tumors. We elucidated the interaction patterns of NF2 and IP3R1, revealed the molecular mechanism through which NF2 regulates IP3R1-mediated Ca2+ release, and elucidated the new pathogenic mechanism of meningioma-related NF2 variants. Our study broadens the current understanding of the biological function of NF2 and provides ideas for drug screening of NF2-associated meningioma.


Assuntos
Apoptose , Sinalização do Cálcio , Cálcio , Receptores de Inositol 1,4,5-Trifosfato , Neoplasias Meníngeas , Meningioma , Animais , Humanos , Camundongos , Cálcio/metabolismo , Linhagem Celular Tumoral , Retículo Endoplasmático/metabolismo , Receptores de Inositol 1,4,5-Trifosfato/metabolismo , Receptores de Inositol 1,4,5-Trifosfato/genética , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/genética , Meningioma/metabolismo , Meningioma/patologia , Meningioma/genética , Neurofibromina 2
11.
Vet Med Sci ; 10(4): e1537, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-39011594

RESUMO

OBJECTIVES: The standard treatment for canine and feline meningiomas includes radiotherapy, surgical excision or combined therapy. However, new therapeutic approaches are required due to the possible recurrence or progression of meningiomas despite initial therapy. Adjunctive therapy with synthetic long-acting somatostatin (SST) analogues has been described in humans with SST-expressing tumours. The expression of SST receptors (SSTRs) by feline meningiomas is currently unknown, and there are little data about canine meningiomas. We hypothesized that SSTR is expressed by canine and feline meningiomas (S1). METHODS: Seven canines and 11 felines with histologically confirmed meningiomas underwent STTR screening. RNA expressions of SSTR1, SSTR2, SSTR3 and SSTR5 (canine) and SSTR1-SSTR 5 (feline) in fresh frozen and formalin-fixed and paraffin-embedded (FFPE) samples were investigated using real-time (RT)-qPCR. The expression of SSTR1 and SSTR2 in FFPE samples was evaluated using immunohistochemistry (IHC). The specificity of applied antibodies for canine and feline species was confirmed by western blotting. RESULTS: In canine meningiomas (n = 7), RNA expression of SSTR1, SSTR2 and SSTR5 was detected in all samples; SSTR3 RNA expression was detected in only 33% of samples. In feline meningiomas (n = 12), RNA expression of SSTR1, SSTR4, SSTR5 and SSTR2 was detected in 91%, 46%, 46% and 36% of samples, respectively; SSTR3 was not expressed. Overall, the detection rate was lower in FFPE samples. IHC revealed the expression of SSTR1 and SSTR2 in all samples from both species. However, it is important to exercise caution when interpreting IHC results due to the presence of diffuse background staining. CONCLUSIONS: SSTRs are widely expressed in canine and feline meningiomas, thereby encouraging further studies investigating SSTR expression to conduct trials about the effect of adjunctive therapy with long-acting SST-analogues.


Assuntos
Doenças do Gato , Doenças do Cão , Meningioma , Receptores de Somatostatina , Receptores de Somatostatina/metabolismo , Receptores de Somatostatina/genética , Animais , Cães , Gatos , Doenças do Gato/metabolismo , Doenças do Gato/genética , Meningioma/veterinária , Meningioma/metabolismo , Meningioma/genética , Doenças do Cão/metabolismo , Doenças do Cão/genética , Neoplasias Meníngeas/veterinária , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/genética , Feminino , Masculino
12.
Clin Nucl Med ; 49(10): 962-963, 2024 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-38968597

RESUMO

ABSTRACT: 18 F-THK5351 demonstrates a strong binding affinity and selectivity for tau. However, off-target binding with monoamine oxidase-B enzyme, highly expressed in the outer mitochondrial membranes of astrocytes, is possible. In a case with isocitrate dehydrogenase-wildtype glioblastoma, 11 C-MET PET and 18 F-THK5351 PET exhibited increased uptake in the tumor. Conversely, in another case with intracranial meningioma, MET PET revealed increased uptake in the tumor, whereas 18 F-THK5351 PET showed no abnormal uptake in the tumor. However, it is challenging to distinguish meningiomas from glioblastomas on MRI. 18 F-THK5351 PET might help differentiate between isocitrate dehydrogenase-wildtype glioblastoma and meningioma.


Assuntos
Glioblastoma , Isocitrato Desidrogenase , Meningioma , Tomografia por Emissão de Pósitrons , Humanos , Meningioma/diagnóstico por imagem , Meningioma/metabolismo , Glioblastoma/diagnóstico por imagem , Glioblastoma/metabolismo , Isocitrato Desidrogenase/metabolismo , Isocitrato Desidrogenase/genética , Aminopiridinas , Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/metabolismo , Neoplasias Encefálicas/diagnóstico por imagem , Neoplasias Encefálicas/metabolismo , Pessoa de Meia-Idade , Transporte Biológico , Masculino , Feminino , Metionina/metabolismo , Quinolinas
13.
Science ; 384(6702): eadh5548, 2024 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-38900896

RESUMO

The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM by abluminal migration along blood vessels that connect vertebral or calvarial bone marrow and meninges, bypassing the blood-brain barrier. This process is dependent on BCC engagement with vascular basement membrane laminin through expression of the neuronal pathfinding molecule integrin α6. Once in the LM, BCCs colocalize with perivascular meningeal macrophages and induce their expression of the prosurvival neurotrophin glial-derived neurotrophic factor (GDNF). Intrathecal GDNF blockade, macrophage-specific GDNF ablation, or deletion of the GDNF receptor neural cell adhesion molecule (NCAM) from BCCs inhibits breast cancer growth within the LM. These data suggest integrin α6 and the GDNF signaling axis as new therapeutic targets against breast cancer LM metastasis.


Assuntos
Neoplasias Ósseas , Neoplasias da Mama , Integrina alfa6 , Neoplasias Meníngeas , Meninges , Vias Neurais , Animais , Feminino , Humanos , Camundongos , Membrana Basal/metabolismo , Neoplasias Ósseas/secundário , Neoplasias Ósseas/metabolismo , Neoplasias da Mama/patologia , Neoplasias da Mama/metabolismo , Neoplasias da Mama/genética , Linhagem Celular Tumoral , Movimento Celular , Fator Neurotrófico Derivado de Linhagem de Célula Glial/genética , Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Integrina alfa6/metabolismo , Laminina/metabolismo , Macrófagos/metabolismo , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/secundário , Meninges/patologia , Invasividade Neoplásica , Moléculas de Adesão de Célula Nervosa/metabolismo , Moléculas de Adesão de Célula Nervosa/genética , Transdução de Sinais , Vias Neurais/metabolismo , Camundongos SCID , Camundongos Knockout
14.
Sci Rep ; 14(1): 14561, 2024 06 24.
Artigo em Inglês | MEDLINE | ID: mdl-38914647

RESUMO

Variations in the biomechanical stiffness of brain tumors can not only influence the difficulty of surgical resection but also impact postoperative outcomes. In a prospective, single-blinded study, we utilize pre-operative magnetic resonance elastography (MRE) to predict the stiffness of intracranial tumors intraoperatively and assess the impact of increased tumor stiffness on clinical outcomes following microsurgical resection of vestibular schwannomas (VS) and meningiomas. MRE measurements significantly correlated with intraoperative tumor stiffness and baseline hearing status of VS patients. Additionally, MRE stiffness was elevated in patients that underwent sub-total tumor resection compared to gross total resection and those with worse postoperative facial nerve function. Furthermore, we identify tumor microenvironment biomarkers of increased stiffness, including αSMA + myogenic fibroblasts, CD163 + macrophages, and HABP (hyaluronic acid binding protein). In a human VS cell line, a dose-dependent upregulation of HAS1-3, enzymes responsible for hyaluronan synthesis, was observed following stimulation with TNFα, a proinflammatory cytokine present in VS. Taken together, MRE is an accurate, non-invasive predictor of tumor stiffness in VS and meningiomas. VS with increased stiffness portends worse preoperative hearing and poorer postoperative outcomes. Moreover, inflammation-mediated hyaluronan deposition may lead to increased stiffness.


Assuntos
Técnicas de Imagem por Elasticidade , Meningioma , Neuroma Acústico , Humanos , Meningioma/cirurgia , Meningioma/metabolismo , Meningioma/patologia , Meningioma/diagnóstico por imagem , Neuroma Acústico/cirurgia , Neuroma Acústico/metabolismo , Neuroma Acústico/patologia , Neuroma Acústico/diagnóstico por imagem , Técnicas de Imagem por Elasticidade/métodos , Feminino , Masculino , Pessoa de Meia-Idade , Biomarcadores Tumorais/metabolismo , Idoso , Estudos Prospectivos , Adulto , Neoplasias Meníngeas/cirurgia , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/diagnóstico por imagem , Resultado do Tratamento , Microambiente Tumoral , Imageamento por Ressonância Magnética/métodos
15.
Turk Neurosurg ; 34(4): 647-654, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38874241

RESUMO

AIM: To investigate the status of immune checkpoint molecules (CTLA-4 and TIM-3) in meningiomas and thus contribute to the development of new personalized treatment strategies. MATERIAL AND METHODS: We utilized 402 cases of meningioma for this study. New blocks were prepared using the tissue microarray method, and sections obtained from these blocks were immunohistochemically stained with CTLA-4 and TIM-3 antibodies. Subsequently, statistical analysis were performed. RESULTS: Our findings revealed that CTLA-4 expression were observed in 25.1% of meningiomas. CTLA-4 expression and the number of expressing lymphocytes were found to be significantly higher in high-grade tumors and in those with brain invasion. Meningiomas with staining of immune cells with TIM-3 are 3.5%, and the tumor grade was correlated with the number of immune cells expressing TIM-3. CONCLUSION: Immune checkpoint molecules (CTLA-4 and TIM-3) with varying levels of expression can serve as prognostic and predictive biomarkers, as well as important targets for therapy. Drugs developed for CTLA-4 and TIM-3 molecules may prove to be more effective in treating meningiomas with high-grade, brain-invading, spontaneous necrosis, and macronucleolus.


Assuntos
Antígeno CTLA-4 , Receptor Celular 2 do Vírus da Hepatite A , Imuno-Histoquímica , Neoplasias Meníngeas , Meningioma , Humanos , Meningioma/imunologia , Meningioma/patologia , Meningioma/metabolismo , Masculino , Neoplasias Meníngeas/imunologia , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/metabolismo , Feminino , Pessoa de Meia-Idade , Antígeno CTLA-4/metabolismo , Antígeno CTLA-4/imunologia , Receptor Celular 2 do Vírus da Hepatite A/metabolismo , Idoso , Adulto , Biomarcadores Tumorais/metabolismo , Proteínas de Checkpoint Imunológico/metabolismo , Idoso de 80 Anos ou mais , Adulto Jovem , Adolescente
16.
Neurosurg Rev ; 47(1): 278, 2024 Jun 17.
Artigo em Inglês | MEDLINE | ID: mdl-38884687

RESUMO

This letter provides a critical assessment of a previous study on the utility of whole tumor apparent diffusion coefficient (ADC) histogram characteristics in predicting meningioma progesterone receptor expression. While acknowledging the benefits of employing classical diffusion-weighted imaging (DWI) for non-invasive tumor evaluation, it also emphasizes significant drawbacks. Advanced imaging techniques such as diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI) were not used in the study, which could have provided a more comprehensive understanding of tumor microstructure and heterogeneity. Furthermore, the inclusion of necrotic and cystic areas in ADC analysis may distort results due to their different diffusion properties. While focusing on first-order ADC histogram characteristics is useful, it ignores the potential insights gained from higher-order features and texture analysis. These limitations indicate that future research should combine improved imaging modalities with thorough analytical methodologies to increase the predictive value of imaging biomarkers for meningioma features and progesterone receptor expression.


Assuntos
Imagem de Difusão por Ressonância Magnética , Neoplasias Meníngeas , Meningioma , Receptores de Progesterona , Meningioma/diagnóstico por imagem , Meningioma/patologia , Meningioma/metabolismo , Humanos , Receptores de Progesterona/metabolismo , Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/metabolismo , Imagem de Difusão por Ressonância Magnética/métodos , Feminino
17.
CNS Neurosci Ther ; 30(6): e14784, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38828669

RESUMO

INTRODUCTION: Programmed death-ligand 1 (PD-L1) expression is an immune evasion mechanism that has been demonstrated in many tumors and is commonly associated with a poor prognosis. Over the years, anti-PD-L1 agents have gained attention as novel anticancer therapeutics that induce durable tumor regression in numerous malignancies. They may be a new treatment choice for neurofibromatosis type 2 (NF2) patients. AIMS: The aims of this study were to detect the expression of PD-L1 in NF2-associated meningiomas, explore the effect of PD-L1 downregulation on tumor cell characteristics and T-cell functions, and investigate the possible pathways that regulate PD-L1 expression to further dissect the possible mechanism of immune suppression in NF2 tumors and to provide new treatment options for NF2 patients. RESULTS: PD-L1 is heterogeneously expressed in NF2-associated meningiomas. After PD-L1 knockdown in NF2-associated meningioma cells, tumor cell proliferation was significantly inhibited, and the apoptosis rate was elevated. When T cells were cocultured with siPD-L1-transfected NF2-associated meningioma cells, the expression of CD69 on both CD4+ and CD8+ T cells was partly reversed, and the capacity of CD8+ T cells to kill siPD-L1-transfected tumor cells was partly restored. Results also showed that the PI3K-AKT-mTOR pathway regulates PD-L1 expression, and the mTOR inhibitor rapamycin rapidly and persistently suppresses PD-L1 expression. In vivo experimental results suggested that anti-PD-L1 antibody may have a synergetic effect with the mTOR inhibitor in reducing tumor cell proliferation and that reduced PD-L1 expression could contribute to antitumor efficacy. CONCLUSIONS: Targeting PD-L1 could be helpful for restoring the function of tumor-infiltrating lymphocytes and inducing apoptosis to inhibit tumor proliferation in NF2-associated meningiomas. Dissecting the mechanisms of the PD-L1-driven tumorigenesis of NF2-associated meningioma will help to improve our understanding of the mechanisms underlying tumor progression and could facilitate further refinement of current therapies to improve the treatment of NF2 patients.


Assuntos
Antígeno B7-H1 , Proliferação de Células , Neoplasias Meníngeas , Meningioma , Neurofibromatose 2 , Linfócitos T , Meningioma/metabolismo , Meningioma/imunologia , Meningioma/patologia , Humanos , Antígeno B7-H1/metabolismo , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/imunologia , Animais , Linfócitos T/metabolismo , Linfócitos T/efeitos dos fármacos , Neurofibromatose 2/metabolismo , Camundongos , Masculino , Feminino , Neurofibromina 2/metabolismo , Neurofibromina 2/genética , Linhagem Celular Tumoral , Pessoa de Meia-Idade , Camundongos Nus , Apoptose/efeitos dos fármacos , Apoptose/fisiologia
18.
Appl Immunohistochem Mol Morphol ; 32(6): 292-304, 2024 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-38863278

RESUMO

OBJECTIVES: To find predictive biomarkers for recurrence and progression of meningioma. BACKGROUND: Despite great advances in meningioma treatment, the prognosis remained unfavorable due to the high recurrence rate. METHODS: In this study, we evaluated the immunohistochemical expression of FOXM1, MMP-9, and Ki67 in 50 cases of intracranial meningioma to detect its potential role in meningioma progression, recurrence, and patients' survival. RESULTS: Strong FOXM1 expression was detected in 20% of the cases and was significantly associated with meningioma grade ( P = 0.002) and peritumoral brain edema (PTBE; P <0.001). Strong MMP-9 expression was noted in 32% of the cases and was significantly associated with meningioma grade and PTBE ( P <0.001, P <0.001, respectively). High Ki67 was noted in 50% and significantly associated with tumor grade and PTBE ( P <0.001, P = 0.002, respectively). The follow-up period revealed that meningiomas with strong FOXM1, strong MMP-9, and high Ki67 expression were associated with tumor recurrence, shorter OS, and recurrence-free survival. Furthermore, up-regulation of FOXM1 and MMP-9 expression had a significant relation with poor clinical response to the therapy ( P = 0.010, P = 0. 001, respectively). However, high Ki67 cases were more sensitive to clinical therapy ( P = 0.005). CONCLUSION: Strong FOXM1, strong MMP-9, and high Ki67 in meningiomas indicate highly aggressive tumors with a shortened survival rate, dismal outcome, and high risk of recurrence after the standard protocol of therapy.


Assuntos
Proteína Forkhead Box M1 , Imuno-Histoquímica , Metaloproteinase 9 da Matriz , Meningioma , Humanos , Proteína Forkhead Box M1/metabolismo , Meningioma/metabolismo , Meningioma/patologia , Meningioma/mortalidade , Feminino , Masculino , Metaloproteinase 9 da Matriz/metabolismo , Pessoa de Meia-Idade , Adulto , Idoso , Gradação de Tumores , Biomarcadores Tumorais/metabolismo , Antígeno Ki-67/metabolismo , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/mortalidade , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/metabolismo , Regulação Neoplásica da Expressão Gênica
19.
EBioMedicine ; 105: 105211, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38917510

RESUMO

BACKGROUND: External radiation therapy (RT) is often a primary treatment for inoperable meningiomas in the absence of established chemotherapy. Histone deacetylase 6 (HDAC6) overexpression, commonly found in cancer, is acknowledged as a driver of cellular growth, and inhibiting HDACs holds promise in improving radiotherapeutic efficacy. Downregulation of HDAC6 facilitates the degradation of ß-catenin. This protein is a key element in the Wnt/ß-catenin signalling pathway, contributing to the progression of meningiomas. METHODS: In order to elucidate the associations and therapeutic potential of HDAC6 inhibitors (HDAC6i) in conjunction with RT, we administered Cay10603, HDAC6i, to both immortalised and patient-derived meningioma cells prior to RT in this study. FINDINGS: Our findings reveal an increase in HDAC6 expression following exposure to RT, which is effectively mitigated with pre-treated Cay10603. The combination of Cay10603 with RT resulted in a synergistic augmentation of cytotoxic effects, as demonstrated through a range of functional assays conducted in both 2D as well as 3D settings; the latter containing syngeneic tumour microenvironment (TME). Radiation-induced DNA damage was augmented by pre-treatment with Cay10603, concomitant with the inhibition of ß-catenin and minichromosome maintenance complex component 2 (MCM2) accumulation within the nucleus. This subsequently inhibited c-myc oncogene expression. INTERPRETATION: Our findings demonstrate the therapeutic potential of Cay10603 to improve the radiosensitisation and provide rationale for combining HDAC6i with RT for the treatment of meningioma. FUNDING: This work was funded by Brain Tumour Research Centre of Excellence award to C Oliver Hanemann.


Assuntos
Desacetilase 6 de Histona , Inibidores de Histona Desacetilases , Meningioma , Humanos , Desacetilase 6 de Histona/antagonistas & inibidores , Desacetilase 6 de Histona/metabolismo , Desacetilase 6 de Histona/genética , Meningioma/radioterapia , Meningioma/patologia , Meningioma/metabolismo , Meningioma/genética , Linhagem Celular Tumoral , Inibidores de Histona Desacetilases/farmacologia , Inibidores de Histona Desacetilases/uso terapêutico , beta Catenina/metabolismo , beta Catenina/genética , Neoplasias Meníngeas/radioterapia , Neoplasias Meníngeas/patologia , Neoplasias Meníngeas/metabolismo , Neoplasias Meníngeas/genética , Via de Sinalização Wnt/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Microambiente Tumoral/efeitos da radiação , Microambiente Tumoral/efeitos dos fármacos , Dano ao DNA/efeitos da radiação
20.
Clin Nucl Med ; 49(10): 987-988, 2024 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-38915173

RESUMO

ABSTRACT: A 65-year-old woman with long-standing symptoms of COVID-19 participated in our clinical study on the role of 68 Ga-FAPI-04 PET/CT in pulmonary fibrosis. Neither sequela parenchymal changes nor 68 Ga-FAPI-04 uptake was observed in the lungs. However, focal 68 Ga-FAPI-04 uptake was localized in a smoothly circumscribed mass observed in the right frontal region. A meningioma diagnosis was made based on the radiological findings.


Assuntos
Neoplasias Meníngeas , Meningioma , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Humanos , Meningioma/diagnóstico por imagem , Meningioma/metabolismo , Feminino , Idoso , Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/metabolismo , Radioisótopos de Gálio , COVID-19/diagnóstico por imagem , COVID-19/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...